Combination of antineoplastic pharmacology, including AVE8062 and SORFENIB, is a basic or butyl acid salt for the treatment of colon tumors such as scabies, lung cancer, ovaries, Rion or liver.
Pharmaceutical Combination comprising AVE8062 and sorafenib or their salts, and their use for the preparation of a combination of Antitumor.Combinación farmacéutica que comprende AVE8062 y sorafenib o sus sales; y su uso para la preparación de una combinación antitumoral.